Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricCVSCVS HealthCICignaDGXQuest Diagnostics
Snapshot
Price$101.30$282.08$193.58
Market cap$125.45B$73.88B$21.59B
Valuation
P/E42.5x11.7x21x
Forward P/E60.7x9x18.3x
Growth
Revenue growth7.6%8.8%11.0%
EPS growth-46.0%30.5%14.9%
Profitability
Net margin0.7%2.3%9.1%
ROE3.9%15.2%14.1%
Balance sheet & cash
Debt / equity0.86x0.75x0.82x
Free cash flow yield9.9%9.7%5.4%
Dividend yield2.6%2.1%1.7%
Verdict
Investment ratingWeak· 32Favorable· 60Neutral· 57

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearCVStoday $101CItoday $282DGXtoday $194
2027$77.49 – $113.66+12% CAGR$276.02 – $404.83+44% CAGR$166.79 – $244.62+26% CAGR
2028$79.04 – $115.93+7% CAGR$360.13 – $528.19+37% CAGR$191.61 – $281.02+20% CAGR
2029$80.63 – $118.25+5% CAGR$469.86 – $689.12+35% CAGR$220.12 – $322.84+19% CAGR
2030$82.24 – $120.62+4% CAGR$613.02 – $899.10+34% CAGR$252.87 – $370.88+18% CAGR
2031$83.88 – $123.03+4% CAGR$799.81 – $1,173.05+33% CAGR$290.50 – $426.06+17% CAGR
5-yr CAGR-3.7% – 4.0%23.2% – 33.0%8.5% – 17.1%